Tudor Investment Corp
ABEO icon

Tudor Investment Corp’s Abeona Therapeutics ABEO Stock Holding History

Tudor Investment Corp’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-474
Closed -$87K – 1067
2019
Q1 		$87K Buy
+474
New +$84.8K ﹤0.01% 1042
2018
Q1 		– Sell
-484
Closed -$192K – 970
2017
Q4 		$192K Sell
484
-800
-62% -$331K ﹤0.01% 968
2017
Q3 		$547K Buy
+1,284
New +$345K 0.01% 604
2017
Q2 		– Sell
-1,340
Closed -$168K – 999
2017
Q1 		$168K Hold
1,340
– – 0.01% 1255
2016
Q4 		$162K Buy
+1,340
New +$210K ﹤0.01% 1258

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tudor Investment Corp's ABEO Position: Q2 2019 in Review

Tudor Investment Corp sold out of Abeona Therapeutics (ABEO) in Q2 2019, closing a stake of 474 shares — an estimated $87K sold.

Tudor Investment Corp first reported a position in ABEO in Q4 2016 and held it in 5 quarters. The position peaked at $547K in Q3 2017. 98 funds tracked by Wall St. Rank hold ABEO as of Q2 2019.

  • Tudor Investment Corp reported no remaining Abeona Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Tudor Investment Corp sold 474 Abeona Therapeutics shares in Q2 2019, an estimated $87K.
  • Tudor Investment Corp first reported a position in Abeona Therapeutics in Q4 2016 and held it in 5 quarters.
  • Tudor Investment Corp's Abeona Therapeutics position peaked at $547K in Q3 2017.
  • 98 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2019.

Based on Tudor Investment Corp's 13F filing for Q2 2019, filed 14 Aug 2019.